A wide range of tests finds clinical application in blood group typing—there are as many as 33 blood group systems. Quite wide array of techniques and instruments have become popular in cross-matching tests in transfusion medicine.
Blood Group Typing Market: Contours of Evolution and Scope
A wide range of tests finds clinical application in blood group typing—there are as many as 33 blood group systems. Quite wide array of techniques and instruments have become popular in cross-matching tests in transfusion medicine. Transfusion-related problems have opened market for new tests for ABO and Rhesus system. These systems aside, a significant number of genetically-different BGs have been identified.
A growing body of research in blood group typing market has also put a slant emphasis on diseases RBC surface antigens can cause. Constant progress that blood transfusion medicine has witnessed world over is testimony to the growing application of conventional as well as some modern tests in blood group typing market. These comprise antibody screening, cross matching test, HLA typing, and antigen typing.
Unarguably, experts consider blood group-linked diseases to be at nascent stage but strikingly evolving. These has attract attention of clinicians in using blood group typing tests for understanding malignancies with chronic diseases. This is a key driver for growing clinical role of ABO blood groups in understanding the severity of infection in chronic diseases. Most importantly, industry players are putting stakes on instruments that are used in blood group typing market, and harness them for expanding the management avenue for cancer.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48627
Blood Group Typing Market: Valuation and Projection
The global blood group typing market stood at US$ 1,500.0 Mn in 2017 and is anticipated to reach US$ 3,556.0 Mn by 2026, expanding at an impressive CAGR of 10.3% from 2018 to 2026.
Blood group typing tests and consumables have gained clinical acceptance due to rise in increase in blood transfusion rate across the world. To a great deal, the need for transfusion processes has risen at rapid pace due to its correlation with hospitalization caused due to various chronic diseases, such as kidney ailments.
The report segments the blood group typing market on the basis of product, technique, test, and end use.
Major end uses comprise instruments, consumables, and services.
PCR-based Techniques Gathered Steam for Blood Grouping for Chronic Diseases
Of all products, consumables accounted for the leading share in 2017 and is expected to retain its lead throughout the forecast period. Constant efforts by researchers to test advanced instruments and kits have helped boost the prominence of the segment. Advancements in analytical devices have bolstered the prospects. Further, rise in demand for molecular diagnostic test kits and reagents
Key techniques used in the blood are PCR-based, microarray-based, assay-based technique, and massively parallel techniques.
Request for Analysis of COVID-19 Impact of Blood Group Typing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=48627
Of these, the PCR-based segment held the leading share in the global market in 2017. It is expected to retain its dominance in coming years as well. The segment is expected to clock a CAGR of 10.6% from 2018 to 2026.
PCR-based techniques have gathered steam for blood grouping for chronic diseases such as aplastic anemia, sickle cell anemia, traumatic injuries, and leukemia. The associated techniques are also useful in rare type of blood group. The second prominent share is held by microarray-based segment.
Assay-based technique and massively parallel techniques held an approximately 30.0% share of the global blood group typing market, vis-à-vis revenue, in 2017.
In coming years, portable blood typing methods will help save the lives of patients who need blood transfusion in emergency settings. Their capabilities have gone rapid advancements on the back of incorporation of sensor technology.
Serologic testing has been popularly used in the blood group typing market. However, in recent years, molecular typing methods are gaining preference due to their capability in advanced blood group typing, such as for predicting the probable antigen type.
Antibody Screening Test Segment to Rise From Demand in Low- and Middle-Income Countries
Of the various test types, the antibody screening test segment is anticipated to hold leading share of global blood group typing market by 2026-end. The segment is projected to clock a CAGR more than 10.0% during 2018 - 2026. In low- and middle-income countries, rise in incidence of transfusion transmitted infections (TTIs) has spurred the demand.
HLA typing and antigen segments jointly accounted for approximately 30.0% share of the global blood group typing market in 2017 in revenues.
Various end-use segments are hospitals, clinical laboratories, and blood bank. Of these, hospitals accounted for the top share. The segment is expected to rise at CAGR of 10% during 2018 - 2026. By the end of the period, it is expected to gain some market shares. Widespread demand for various test types makes the segment highly lucrative for market players.
Buy Blood Group Typing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=48627<ype=S
North America Held the Top Share
The various regional markets for blood group typing are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Of these, North America is the leading segment and is expected to gain share. A great deal of fillip for the uptick in demand for various types of blood group typing comes from active and voluntary blood donors in the U.S. Also, rapid strides have been made by life-saving transfusion medicine, paving way for new avenues for prenatal patients.
Rise in number of blood donors in Asia Pacific has spurred the demand for blood group typing. China is expected to a lucrative market and will rise at an impressive growth rate during 2018 – 2026.
Top players profiled in the report are Grifols, S.A., Bio-Red Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., eckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., and Novacyt Group.
Browse More Trending Reports by Transparency Market Research:
Metabolism Drugs Market: https://www.transparencymarketresearch.com/metabolism-drugs-market.html
Automated Endoscopy Reprocessor Market: https://www.transparencymarketresearch.com/automated-endoscopy-reprocessor-market.html
Nicotine Replacement Therapy Market: https://www.transparencymarketresearch.com/nicotine-replacement-therapy-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/